During the past decade, Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are "Cardiovascular Disease" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" in a lesser frequency.

Most popular intervention types in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".